Meghna Rao

Researchers evaluated the efficacy of low-dose denosumab for maintaining bone mineral density in postmenopausal women with osteoporosis.

Researchers investigated the effects of canagliflozin on serum urate levels and gout in patients with type 2 diabetes.

The study identified biomarkers for changes in bone mineral density at three anatomic sites in patients with osteoporosis secondary to RA.